http://rdf.ncbi.nlm.nih.gov/pubchem/reference/29830077

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 386
issn 1179-1322
pageRange 377-386
publicationName Cancer Management and Research
startingPage 377
bibliographicCitation Yuan C, Huang M, Wang H, Jiang W, Su C, Zhou S. Pretreatment Fibrinogen-Albumin Ratio (FAR) Associated with Treatment Response and Survival in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Anti-PD-1 Therapy Plus Platinum-Based Combination Chemotherapy. Cancer Manag Res. 2022;14():377–86. PMID: 35115834; PMCID: PMC8801367.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a4e87bd4ba254421bb020d65e6c97e06
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f52ff46bac6faf7ccb4f34333a2d49be
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_db4944cd35f459828c5f24c6e38d7ed0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_741734cd7dc29bb1028a5f74caeee1c9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d9370741c58e680e3d811dd102518f93
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_296cd8fc86bcb1e87844b2bfc7964b7c
date 202201
identifier https://pubmed.ncbi.nlm.nih.gov/35115834
https://pubmed.ncbi.nlm.nih.gov/PMC8801367
https://doi.org/10.2147/cmar.s347547
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/36231
https://portal.issn.org/resource/ISSN/1179-1322
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Pretreatment Fibrinogen-Albumin Ratio (FAR) Associated with Treatment Response and Survival in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Anti-PD-1 Therapy Plus Platinum-Based Combination Chemotherapy
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_73717aafac1e7701dab0fa02b8936926
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23939
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b83d04d3e3b05ce10d1a5893dc850a9b

Total number of triples: 27.